The raised guidance and accelerating Adjusted EBITDA growth (44% in Q2) signal strong operational momentum and successful integration of the Amedisys/LHC branches. Monitor the Q3 earnings call for updates on the Community Living divestiture cash deployment and any further debt paydown or share repurchase activity.
Price Chart
Executive Summary
BrightSpring Health Services reported Q2 2026 revenue of $3.873B (+23% YoY) and GAAP diluted EPS of $0.39, slightly below the $0.40 consensus. The company raised its full-year 2026 revenue guidance to $15.1B-$15.425B and Adjusted EBITDA guidance to $820M-$845M, reflecting strong operational momentum and the benefit of the Amedisys/LHC acquisition. The beat on guidance and continued deleveraging to 2.15x offset the marginal EPS miss, making this a fundamentally positive report.
Key Financial Metrics
Key Facts
- Q2 2026 revenue of $3.873B, up 23.0% YoY from $3.148B
- GAAP diluted EPS from continuing operations of $0.39 vs consensus $0.40 (2.5% miss)
- Adjusted EBITDA of $206M, up 44.2% YoY from $143M
- Full-year 2026 revenue guidance raised to $15.1B-$15.425B (17.0%-19.5% growth)
- Full-year 2026 Adjusted EBITDA guidance raised to $820M-$845M (32.8%-36.8% growth)
- Leverage reduced to 2.15x from 2.27x at Q1 2026; $300M debt paydown completed
- Pharmacy Solutions revenue grew 22% to $3.407B; Provider Services revenue grew 30% to $466M
- Home Health Care average daily census surged 54% to 46,448, driven by Amedisys/LHC acquisition
Financial Impact
Raised FY2026 revenue guidance by ~$650M at midpoint and Adjusted EBITDA guidance by ~$57.5M at midpoint vs prior guidance
Risk Factors
- Integration risk from the Amedisys/LHC acquisition and potential margin pressure from rising labor costs
- Medicare/Medicaid reimbursement rate changes could impact Pharmacy Solutions revenue per script growth
- Execution risk on achieving the upper end of raised guidance range given macro uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-326654 |
| Document: btsg-20260731.htm | 0001193125-26-326654 |
| Document: 0001193125-26-326654-index-headers.html | 0001193125-26-326654 |
| Document: 0001193125-26-326654-index.html | 0001193125-26-326654 |
| Document: 0001193125-26-326654.txt | 0001193125-26-326654 |
| 8-K Data (Synthetic) | 0001193125-26-326654 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | Institutional Cluster | $60.60 $61.43 | ▲ +1.37% | ▲ +0.77% | $60.25 (−0.58%) |
Jul 31, 2026 9w ago | 8-K | $59.71 $59.13 | ▼ −0.97% | ▼ −3.96% | $60.25 (+0.90%) |
Jul 31, 2026 9w ago | Press Release | $59.71 $59.13 | ▼ −0.97% | ▼ −3.96% | $60.25 (+0.90%) |
Jul 8, 2026 12w ago | Press Release | $71.58 $60.60 | ▼ −15.34% | ▼ −17.58% | $60.25 (−15.83%) |
Jun 11, 2026 16w ago | Institutional Cluster | $63.08 $71.58 | ▲ +13.47% | ▲ +11.58% | $60.25 (−4.49%) |
Jun 5, 2026 16w ago | Insider Cluster | $59.22 $70.56 | ▼ −19.15% | ▼ −17.52% | $60.25 (−1.74%) |
Jun 5, 2026 16w ago | Insider Cluster | $59.22 $70.56 | ▲ +19.15% | ▲ +17.52% | $60.25 (+1.74%) |
Jun 5, 2026 16w ago | Insider Cluster | $59.22 $70.56 | ▼ −19.15% | ▼ −17.52% | $60.25 (−1.74%) |
Jun 4, 2026 17w ago | Press Release | $57.40 $69.03 | ▲ +20.26% | ▲ +21.63% | $60.25 (+4.97%) |
May 1, 2026 22w ago | Press Release | $52.58 $59.98 | ▲ +14.07% | ▲ +8.79% | $60.25 (+14.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access